N-(4-fluorobenzyl)-1,1-bis(2-methoxyphenyl)-3-oxotetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide

ID: ALA5086131

Chembl Id: CHEMBL5086131

PubChem CID: 166635930

Max Phase: Preclinical

Molecular Formula: C28H28FN3O5

Molecular Weight: 505.55

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccccc1C1(c2ccccc2OC)OC(=O)N2CCN(C(=O)NCc3ccc(F)cc3)CC21

Standard InChI:  InChI=1S/C28H28FN3O5/c1-35-23-9-5-3-7-21(23)28(22-8-4-6-10-24(22)36-2)25-18-31(15-16-32(25)27(34)37-28)26(33)30-17-19-11-13-20(29)14-12-19/h3-14,25H,15-18H2,1-2H3,(H,30,33)

Standard InChI Key:  DBEWUXIACHOUHG-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5086131

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 505.55

Molecular Weight (Monoisotopic): 505.2013

AlogP: 4.13

#Rotatable Bonds: 6

Polar Surface Area: 80.34

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 3.73

CX LogD: 3.73

Aromatic Rings: 3

Heavy Atoms: 37

QED Weighted: 0.55

Np Likeness Score: -0.81

References

1. Albanese V, Ruzza C, Marzola E, Bernardi T, Fabbri M, Fantinati A, Trapella C, Reinscheid RK, Ferrari F, Sturaro C, Calò G, Amendola G, Cosconati S, Pacifico S, Guerrini R, Preti D..  (2021)  Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity.,  64  (7.0): [PMID:33733768] [10.1021/acs.jmedchem.0c02223]

Source

Source(1):

• Scientific Literature